MetLife Investment Management’s N-able NABL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$189K Buy
40,384
+3,828
+10% +$21.4K ﹤0.01% 2261
2025
Q4
$273K Sell
36,556
-9,782
-21% -$74.7K ﹤0.01% 2119
2025
Q3
$361K Hold
46,338
﹤0.01% 1972
2025
Q2
$375K Hold
46,338
﹤0.01% 1814
2025
Q1
$329K Sell
46,338
-864
-2% -$7.69K ﹤0.01% 1931
2024
Q4
$441K Buy
47,202
+4,906
+12% +$55K ﹤0.01% 1872
2024
Q3
$552K Hold
42,296
﹤0.01% 1731
2024
Q2
$644K Buy
42,296
+5,028
+13% +$66.2K ﹤0.01% 1586
2024
Q1
$487K Hold
37,268
﹤0.01% 1691
2023
Q4
$494K Hold
37,268
﹤0.01% 1687
2023
Q3
$481K Hold
37,268
﹤0.01% 1665
2023
Q2
$537K Hold
37,268
﹤0.01% 1654
2023
Q1
$492K Hold
37,268
﹤0.01% 1652
2022
Q4
$383K Hold
37,268
﹤0.01% 1817
2022
Q3
$344K Hold
37,268
﹤0.01% 1902
2022
Q2
$335K Buy
37,268
+36,478
+4,617% +$357K ﹤0.01% 1947
2022
Q1
$7.19K Buy
+790
New +$8.33K ﹤0.01% 2724

Other funds holding NABL

MetLife Investment Management's NABL Position: Q1 2026 in Review

MetLife Investment Management increased its N-able (NABL) stake by 10% in Q1 2026, buying an estimated $21.4K and bringing the position to 40,384 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

MetLife Investment Management first reported a position in NABL in Q1 2022 and has held it in 17 quarters since. The position peaked at $644K in Q2 2024. 215 funds tracked by Wall St. Rank hold NABL as of Q1 2026.

  • MetLife Investment Management held 40,384 shares of N-able worth $189K as of Q1 2026.
  • MetLife Investment Management bought 3,828 N-able shares in Q1 2026, an estimated $21.4K.
  • N-able made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2261 holding.
  • MetLife Investment Management first reported a position in N-able in Q1 2022 and has held it in 17 quarters since.
  • MetLife Investment Management's N-able position peaked at $644K in Q2 2024.
  • 215 funds tracked by Wall St. Rank held N-able as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.